Literature DB >> 25627062

The nucleobase adenine as a signalling molecule in the kidney.

D Thimm1, A C Schiedel, J Peti-Peterdi, B K Kishore, C E Müller.   

Abstract

In 2002, the first receptor activated by the nucleobase adenine was discovered in rats. In the past years, two adenine receptors (AdeRs) in mice and one in Chinese hamsters, all of which belong to the family of G protein-coupled receptors (GPCRs), were cloned and pharmacologically characterized. Based on the nomenclature for other purinergic receptor families (P1 for adenosine receptors and P2 for nucleotide, e.g. ATP, receptors), AdeRs were designated P0 receptors. Pharmacological data indicate the existence of G protein-coupled AdeRs in pigs and humans as well; however, those have not been cloned so far. Current data suggest a role for adenine and AdeRs in renal proximal tubules. Furthermore, AdeRs are suggested to be functional counterplayers of vasopressin in the collecting duct system, thus exerting diuretic effects. We are only at the beginning of understanding the significance of this new class of purinergic receptors, which might become future drug targets.
© 2015 Scandinavian Physiological Society. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  G protein-coupled receptor; adenine receptor; chronic kidney disease; kidney; nucleobase

Mesh:

Substances:

Year:  2015        PMID: 25627062     DOI: 10.1111/apha.12452

Source DB:  PubMed          Journal:  Acta Physiol (Oxf)        ISSN: 1748-1708            Impact factor:   6.311


  8 in total

1.  Adenine acts in the kidney as a signaling factor and causes salt- and water-losing nephropathy: early mechanism of adenine-induced renal injury.

Authors:  Ingrid F Dos Santos; Sulaiman Sheriff; Sihame Amlal; Rafeeq P H Ahmed; Charuhas V Thakar; Hassane Amlal
Journal:  Am J Physiol Renal Physiol       Date:  2019-01-09

Review 2.  CD39-adenosinergic axis in renal pathophysiology and therapeutics.

Authors:  Bellamkonda K Kishore; Simon C Robson; Karen M Dwyer
Journal:  Purinergic Signal       Date:  2018-01-13       Impact factor: 3.765

Review 3.  Regulation of Vascular and Renal Function by Metabolite Receptors.

Authors:  János Peti-Peterdi; Bellamkonda K Kishore; Jennifer L Pluznick
Journal:  Annu Rev Physiol       Date:  2015-11-19       Impact factor: 19.318

4.  Adenine attenuates the Ca(2+) contraction-signaling pathway via adenine receptor-mediated signaling in rat vascular smooth muscle cells.

Authors:  Toshihiko Fukuda; Takahiro Kuroda; Miki Kono; Mai Hyoguchi; Satoshi Tajiri; Mitsuru Tanaka; Yoshinori Mine; Toshiro Matsui
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-06-18       Impact factor: 3.000

5.  Mechanisms of the action of adenine on anti-allergic effects in mast cells.

Authors:  Toru Hosoi; Shinsuke Ino; Fumie Ohnishi; Kenichi Todoroki; Michiko Yoshii; Mai Kakimoto; Christa E Müller; Koichiro Ozawa
Journal:  Immun Inflamm Dis       Date:  2017-11-01

Review 6.  Small Molecules Enhance Scaffold-Based Bone Grafts via Purinergic Receptor Signaling in Stem Cells.

Authors:  Patrick Frank Ottensmeyer; Markus Witzler; Margit Schulze; Edda Tobiasch
Journal:  Int J Mol Sci       Date:  2018-11-14       Impact factor: 5.923

7.  Adenine attenuates lipopolysaccharide-induced inflammatory reactions.

Authors:  Prashanta Silwal; Kyu Lim; Jun-Young Heo; Jong Il Park; Uk Namgung; Seung-Kiel Park
Journal:  Korean J Physiol Pharmacol       Date:  2018-06-25       Impact factor: 2.016

Review 8.  Recommended tool compounds and drugs for blocking P2X and P2Y receptors.

Authors:  Christa E Müller; Vigneshwaran Namasivayam
Journal:  Purinergic Signal       Date:  2021-09-02       Impact factor: 3.765

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.